Free Research Report as Cabot’s Earnings Surged 9.41%

Stock Monitor: Kraton Post Earnings Reporting

LONDON, UK / ACCESSWIRE / March 02, 2018 / Active-Investors.com has just released a free earnings report on Cabot Corp. (NYSE: CBT). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=CBT. The Company reported its financial results on February 06, 2018, for the first quarter of the fiscal year 2018 ending December 31, 2017. The specialty chemicals and performance materials Company reported significant improvements in its operating performance in Q1 FY18, especially in the Reinforcement Materials and Purification Solutions segments. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for Kraton Corporation (NYSE: KRA), which also belongs to the Basic Materials sector as the Company Cabot. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=KRA

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Cabot most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=CBT

Earnings Highlights and Summary

For the first quarter of the fiscal year 2018, Cabot’s net sales and other operating revenues reached $710 million, up 17.84% from $611 million in Q1 FY17. The revenue numbers outpaced analysts’ consensus estimates of $644 million.

Cabot’s cost of sales hiked 19.91% to $542 million in Q1 FY18 from $452 million in Q1 FY17. The Company’s gross profit was $178 million for the reported quarter, which was 11.95% higher than $159 million in the same period of last year.

Cabot’s selling and administrative expenses jumped 9.52% to $69 million y-o-y and research and technical expenses increased 25% to $15 million y-o-y in the quarter ended December 31, 2017. The Company’s income from continuing operations before income taxes and equity in earnings of affiliated Companies was $92 million, up 22.67% from $75 million in Q1 FY17.

Cabot’s net loss attributable to common shareholders was $122 million for the reported quarter, a decrease of 321.82% from a net income attributable to common shareholders of $55 million from the year-ago same quarter. Cabot’s diluted loss per share attributable to common shareholders was $1.98 in Q1 FY18 compared to diluted earnings per share (EPS) attributable to common shareholders of $0.86 in Q1 FY17. The Company’s reported net income included an after-tax charge of $180 million due to the federal Tax Cuts and Jobs Act 2017 (TCJA). The Company’s adjusted diluted EPS, excluding non-recurring and non-core items, was $0.93 in Q1 FY18, an increase of 9.41% from $0.85 in Q1 FY17. This was higher than analysts’ consensus estimates of $0.78 per share.

Segment Details

During Q1 FY18, Cabot’s Reinforcement Materials segment reported net revenues of $387 million, up 31.19% from $295 million in Q1 FY17. This was mainly due to 2017 calendar year customer agreements and a strong Asia spot pricing. The segment’s earnings before interest and taxes (EBIT) were $62 million in the quarter under review, an increase of 55% from $40 million in the year-ago comparable quarter. Q1 FY18 was the strongest EBIT quarter for the Reinforcement Materials segment since Q1 FY14.

Cabot’s Performance Chemicals segment reported revenues of $229 million in Q1 FY18, up 11.17% from $205 million in Q1 FY17. The segment’s EBIT fell 4.08% to $47 million in the reported quarter from $49 million in the previous year’s corresponding quarter. This was because price increases were more than offset by higher raw material costs and fixed costs.

For Q1 FY18, Cabot’s Purification Solutions segment generated revenues of $70 million, an increment of 1.45% from $69 million in Q1 FY17. For the quarter ended December 31, 2017, the segment reported EBIT of $6 million, 50% up from $4 million in the same period of last year. This was primarily due to a continued momentum in the Specialty applications and the timing of royalty receipts.

Cabot’s Specialty Fluids segment reported revenues of $6 million in Q1 FY18 compared to $11 million in Q1 FY17, reflecting a decrease of 45.45%. This decrease was attributed to a lower project activity and fines cesium chemicals volumes. The segment reported a loss before interest and taxes of $2 million in Q1 FY18 compared to EBIT of $2 million in Q1 FY17.

Cash Matters

Cabot had cash and cash equivalents of $189 million as on December 31, 2017, 32.50% lower than $280 million as on September 30, 2017. The Company’s long-term debt was down 30.9% to $631 million y-o-y as on December 31, 2017.

For the quarter ended December 31, 2017, Cabot’s net cash flow from operating activities was $45 million, a decrease of 57.94% from $107 million for the same period of 2016. The Company had a discretionary free cash flow of $53 million at the end of Q1 FY18.

Cabot’s capital expenditure was $52 million for the first quarter of the fiscal year 2018. The Company returned $36 million to shareholders through dividends and share repurchases in the reported quarter. Of this, Cabot distributed $20 million as cash dividends and spent $16 million on share repurchases.

Outlook

For the full fiscal year 2018, Cabot expects adjusted EPS to be in the range of $3.80 to $4.20. The Company anticipates its Reinforcement Materials segment to benefit from the calendar year 2018 customer agreements, along with a firm spot market in Europe and Asia. For the Performance Chemicals segment, the Company envisions sequential improvement due to higher seasonal volumes and the positive impact from price increases. However, increasing feedstock costs in specialty carbons and higher for growth investments would impact Performance Chemicals segment’s margins. Besides, Cabot expects its Purification Solutions segment to benefit from a continued momentum in the Specialty applications, though it would be challenged by continued competitive ECS pricing.

Stock Performance Snapshot

March 01, 2018 – At Thursday’s closing bell, Cabot’s stock marginally climbed 0.03%, ending the trading session at $60.20.

Volume traded for the day: 426.43 thousand shares.

Stock performance in the previous six-month period – up 15.79%; and past twelve-month period – up 1.78%

After yesterday’s close, Cabot’s market cap was at $3.73 billion.

Price to Earnings (P/E) ratio was at 15.16.

The stock has a dividend yield of 2.09%.

The stock is part of the Basic Materials sector, categorized under the Specialty Chemicals industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 491451